Tinea incognito

Clin Dermatol. 2010 Mar 4;28(2):137-9. doi: 10.1016/j.clindermatol.2009.12.011.

Abstract

Tinea incognito was first described 50 years ago. It is a dermatophytic infection with a clinical presentation modified by previous treatment with topical or systemic corticosteroids, as well as by the topical application of immunomodulators such as pimecrolimus and tacrolimus. Tinea incognito usually resembles neurodermatitis, atopic dermatitis, rosacea, seborrheic dermatitis, lupus erythematosus, or contact dermatitis, and the diagnosis is frequently missed or delayed.

MeSH terms

  • Administration, Cutaneous
  • Antifungal Agents / therapeutic use*
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Contact / diagnosis
  • Dermatitis, Seborrheic / diagnosis
  • Dermatologic Agents / therapeutic use*
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Discoid / diagnosis
  • Neurodermatitis / diagnosis
  • Ointments / therapeutic use
  • Rosacea / diagnosis
  • Tacrolimus / analogs & derivatives
  • Tacrolimus / therapeutic use
  • Tinea / diagnosis*
  • Tinea / drug therapy*
  • Tinea / microbiology
  • Trichophyton / isolation & purification

Substances

  • Antifungal Agents
  • Dermatologic Agents
  • Immunosuppressive Agents
  • Ointments
  • pimecrolimus
  • Tacrolimus